NCT00387829

Brief Summary

To evaluate the safety and effectiveness of DuraGen Plus® Adhesion Barrier Matrix as an adhesion barrier in spinal surgery to reduce the extent of peridural fibrosis formation and radicular pain in comparison to a control group receiving standard care.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
347

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2006

Longer than P75 for not_applicable

Geographic Reach
1 country

36 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2006

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

October 12, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 13, 2006

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
2 years until next milestone

Results Posted

Study results publicly available

November 20, 2013

Completed
Last Updated

September 7, 2017

Status Verified

August 1, 2017

Enrollment Period

4.2 years

First QC Date

October 12, 2006

Results QC Date

June 7, 2013

Last Update Submit

August 7, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Radiological, Pain, and Functional Outcome Assessments

    Radiological score (MRI Outcome score): MRI peridural fibrosis in 5 consecutive 2-D axial Spin Echo T1 axial slices. Score consists of the ratio of total available space in each image and the amount of scar identified (percentage). Pain (VAS): Visual Analog Score used to rate the subject's pain.VAS scale is a 100 mm horizontal line, where the far left side of the scale equals (0) no pain and the far right side of the scale (100) equals the worst possible pain. Functional outcome score (ODI): Used to assess the effect leg or back pain on everyday life. Questions relate to areas such as walking, lifting, sitting, ability to travel as well as other common activities. Ten questions with scores from 0-5. Calculated as percentage: (Actual score /Maximum overall score (worst disability))\*100.

    6 months

Secondary Outcomes (1)

  • Radiological, Pain, and Functional Outcome Assessments

    12 months

Study Arms (2)

1

ACTIVE COMPARATOR

Use of DuraGen Plus Adhesion Barrier Matrix as an adhesion barrier in the spine

Device: DuraGen Plus Adhesion Barrier Matrix

2

NO INTERVENTION

Control arm is surgery alone (no adhesion barrier)

Interventions

Application of DuraGen Plus Adhesion Barrier Matrix in spine surgery

1

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with radicular pain requiring single-level, lumbar hemi-laminectomy or hemilaminotomy procedures with discectomy in the lower lumbar spine
  • Require initial open lumbar surgery for extruded, prolapsed or bulging intervertebral discs
  • Requires removal of herniated disc fragment

You may not qualify if:

  • Current or historic open traumatic injury to the spine
  • Any previous surgery to the lumbar spine or percutaneous tissue destruction or ablation procedures
  • Women who are nursing, women who are pregnant and women who are planning to become pregnant during the time of the study
  • Any spinal conditions or systemic diseases that would preclude the patient from participation in the clinical trial
  • Clinically significant structural disorders
  • Known positive for HIV
  • Insulin-dependent Diabetes Mellitus patients
  • Morbid obesity (Body Mass Index greater than or equal to 40 kg/m2)
  • History of alcohol or drug abuse within 2 years prior to randomization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (36)

Ronderos Neurosurgery Center, Providence Hospital

Mobile, Alabama, 36608, United States

Location

Spine Source

Beverly Hills, California, 90212, United States

Location

Cedars-Sinai Medical Center

Los Angeles, California, 90048, United States

Location

Mission Hospital

Mission Viejo, California, 92691, United States

Location

University of California, San Diego

San Diego, California, 92103, United States

Location

Spine Institute

Santa Monica, California, 90404, United States

Location

Southern California Orthopedic Institute

Van Nuys, California, 91405, United States

Location

Greenwich Neurosurgery/Greenwich Hospital

Greenwich, Connecticut, 06830, United States

Location

Orthopaedic Specialties Spine Center

Clearwater, Florida, 33756, United States

Location

The Back Center

Melbourne, Florida, 32901, United States

Location

University of Miami

Miami, Florida, 33136, United States

Location

Tallahassee Neurological Clinic

Tallahassee, Florida, 32308, United States

Location

University of South Florida

Tampa, Florida, 33606, United States

Location

Southeastern Orthopedic Center

Savannah, Georgia, 31405, United States

Location

Northwestern University

Chicago, Illinois, 60611, United States

Location

Chicago Institute of Neurosurgery and Neuroresearch

Chicago, Illinois, 60640, United States

Location

OSF Saint Francis Medical Center

Peoria, Illinois, 61637, United States

Location

Bluegrass Orthopedics

Lexington, Kentucky, 40509, United States

Location

Interactive Neuroscience Center

Shreveport, Louisiana, 71119, United States

Location

Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States

Location

Columbia Orthopedic Group

Columbia, Missouri, 65205, United States

Location

Montana Neuroscience Institute Foundation

Missoula, Montana, 59802, United States

Location

William S. Muir, MD, PC

Las Vegas, Nevada, 89169, United States

Location

University of Medicine and Dentistry of New Jersey

New Brunswick, New Jersey, 08901, United States

Location

University of Cincinnati Medical Center / Mayfield Clinic

Cincinnati, Ohio, 45267, United States

Location

The Cleveland Clinic Spine Institute

Cleveland, Ohio, 44195, United States

Location

Central Ohio Neurological Surgery

Westerville, Ohio, 43081, United States

Location

Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania, 17033, United States

Location

Princeton Brain and Spine Care

Langhorne, Pennsylvania, 19047, United States

Location

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Roger Williams Hospital

Providence, Rhode Island, 02908, United States

Location

Texas Back Institute

Plano, Texas, 75093, United States

Location

University of Virginia

Charlottesville, Virginia, 22903, United States

Location

Virginia Commonwealth University Health System

Richmond, Virginia, 23298, United States

Location

Orthopedics Intl.

Seattle, Washington, 98122, United States

Location

Swedish Neuroscience Institute

Seattle, Washington, 98122, United States

Location

MeSH Terms

Conditions

Spinal InjuriesTissue Adhesions

Condition Hierarchy (Ancestors)

Back InjuriesWounds and InjuriesCicatrixFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Director of Medical Affairs
Organization
Intergra LifeSciences

Study Officials

  • Edward Benzel, MD

    The Cleveland Clinic Spine Institute

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
GT60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 12, 2006

First Posted

October 13, 2006

Study Start

October 1, 2006

Primary Completion

December 1, 2010

Study Completion

December 1, 2011

Last Updated

September 7, 2017

Results First Posted

November 20, 2013

Record last verified: 2017-08

Locations